Literature DB >> 4614896

Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancer.

D L Ahmann, H F Bisel, R T Eagan, J H Edmonson, R G Hahn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4614896

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  16 in total

Review 1.  Systemic therapy of advanced breast cancer.

Authors:  H T Mouridsen
Journal:  Drugs       Date:  1992       Impact factor: 9.546

2.  Activity of intravenous menogaril in patients with previously untreated metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group study.

Authors:  E A Eisenhauer; K I Pritchard; D J Perrault; S Verma; J L Pater
Journal:  Invest New Drugs       Date:  1990-08       Impact factor: 3.850

3.  Individual human tumors in short-term micro-organ cultures: chemosensitivity testing by fluorescent cytoprinting.

Authors:  B Rotman; C Teplitz; K Dickinson; J P Cozzolino
Journal:  In Vitro Cell Dev Biol       Date:  1988-11

4.  Adriamycin and VP16-213 combination treatment for breast cancer previously treated by the CMF regimen.

Authors:  G Perez Manga; P Madrigal Alonso; H Alburquerque Carbuccia
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

5.  Weekly low dose doxorubicin monotherapy in metastatic breast cancer resistant to previous hormonal and cytostatic treatment.

Authors:  W Scheithauer; C Zielinksi; H Ludwig
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

Review 6.  Adjuvant chemotherapy in breast cancer: To use or not to use, the anthracyclines.

Authors:  Jennifer A Crozier; Abhisek Swaika; Alvaro Moreno-Aspitia
Journal:  World J Clin Oncol       Date:  2014-08-10

7.  Mitoxantrone as first-line chemotherapy in advanced breast cancer: results of a collaborative European study.

Authors:  H T Mouridsen; M Cornbleet; R Stuart-Harris; I Smith; R Coleman; R Rubens; M McDonald; H Rainer; A van Oosterom; J Smyth
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

Review 8.  Heat shock proteins and drug resistance.

Authors:  S A Fuqua; S Oesterreich; S G Hilsenbeck; D D Von Hoff; J Eckardt; C K Osborne
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 9.  Chemotherapy of breast cancer.

Authors:  L S Perlow; J F Holland
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

10.  [Adriamycin, cyclophosphamide, and 5-fluorouracil in the treatment of metastasizing breast cancer (author's transl)].

Authors:  K Höffken; S Seeber; W R Boecker; C G Schmidt
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.